QVT is a New York-based venture capital investor backing private companies from pre-seed and Series A through later-stage rounds. It invests across the United States, Israel and Asia, with activity spanning biotechnology, pharmaceuticals, life sciences, deep tech, computing, clean energy, semiconductors, transportation and finance. The firm has backed healthcare and biotech companies including Pharmasset, Medivation and Roivant Sciences, along with private technology opportunities.